Clinical Trial Update: Topical Chemoprevention of Skin Cancer Biomarkers [Phase 2]

View source ↗

Summary

Phase 2 study evaluating topical chemoprevention biomarkers for non-melanoma skin cancer has completed, reporting results from biomarker endpoints.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-melanoma Skin Cancer

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Non-melanoma Skin Cancer | Phase 2 | Status: COMPLETED